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As a biology model for the analysis of GVHR, caused by con-
tinuously supplied immunocompetent cells of a lymphoid tissue rich 
organ, small intestine (SI) transplantation was performed in rats. 
MATERIALS AND METHODS 
Animals 
Rats of the inbred strains LEW (RTll), BN (RTln), F344 
(RTllvl), CAP (RTIC) and their Fl-progeny were used; recipients 
at the age of 6, graft donors at the age of 3-4 months. 
!echnique of SI Transplantation 
For transplantation of SI the so~ca1led bypass technique was 
used, which consists of grafting the organ heterotopically as an 
aUXilliary organ (Fig. 1): the aboral end of the graft was anasto-
mozed in an end-to-side technique to the recipient's terminal ileum, 
while the oral end of the graft was closed with a circular ligature. 
Test Procedure for Cell Mediated In Vitro Reactivity 
Cell mediated in vitro reactivity of the various lymphatic 
compartments of the recipient (blood ~ bl, spleen = sp, peripheral 
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FIG. 1. Schematic outline of heterotopic small intestine trans-
plantation. 
lymph nodes = pIn, mesenteric lymph nodes ~ mln, Peyer patches = 
pp) and of the graft (mesenteric lymph nodes = mln-gr, Peyer 
patches = pp-gr) was tested at different times (14-30, 50 or 
90-110 days) p.op_ using the microcytotoxicity assay, MeA (1). 
Embryonic fibroblasts of parental strains and a third party 
strain served as target cells. 
Experimental Groups 
Four experimental groups were formed, grafting either total 
of half SI of parental origin into Fl-hybrids I. 1/1 F344 + 
(F344 x CAP)Fl, 11. 1/2 F344 + (F344 x CAP)Fl, Ill. 1/1 BN + 
(LEW x BN)Fl and IV. 1/2 BN + (LEW x BN)Fl' 
RESULTS 
Mortality Rates 
GVHR induced mortality pf semi allogeneic graft recipients in 
the four experimental groups is shown in Fig. 2. As can be seen, 
mortality of SI recipients clearly depends on (a) the kind of 
strain combination used and (b) the amount of lymphatic tissue 
grafted (total or half SI). 
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FIG. 2. Survival of small intestine graft recipients. 
,Characterization of GVHR 
For measuring GVHR, embryonic fibroblasts from that parental 
strain which did not provide the graft, were used as targets. 
Figs. 3-5 demonstrate cell compartment, strain combination and 
serum factor dependence of in vitro measurable GVHR. With regard 
to cell compartment dependence, two main patterns have been 
observed: (a) lack of reactivity in the transport compartment 
blood combined with reactivity in the various lymphatic tissue 
compartments, interestingly including donor and recipient Peyer 
patches; (b) remarkable reactivity in the transport compartment 
blood combined with reactivity in the various lymphatic tissues, 
excluding donor and recipient Peyer patches, These strongly 
differing patterns appear to be correlated with the mortality 
rates in the strain combinations studied, in so far as GVH-
reactivity in blood is oBserved in animals which die within the 
following week. On the other hand, long term survivors without 
blood compartment reactivity contain factors in their serum which 
are able to inhibit cell mediated reactivity (Fig. 5) • 
.9haracterization of "Self-Constituents-reactivity" (SCR) 
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For measuring SeR, embryonic fibroblasts from that parental 
strain which did provide the graft, were used as target cells. As 
eVident from Figs. 3-5 the observed SCR follows the same pattern 
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FIG. 3. Cell mediated in vitro reactivity of the various lympha-
tic compartments of the recipient and of the graft in group I. 
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FIG. 4. Cell mediated in vitro reactivity of the various lympha-
tic compartments of the recipient and of the graft in group Ill. 
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FIG. 5. Inhibition of cell mediated in vitro reactivity by serum. 
of appearance as that of GVHR, i.e., it shows cell compartment, 
strain combination and serum factor dependence. However, though 
dependent on GVHR, it follows independent kinetics, when 
measuring both reactivities on day 25, 50 and 110 p. Ope (data 
not shown in Figs.). 
Further Characterization of Reactive Cells and Targets 
Reactive spleen cells were shown to be SAL sensitive, that is 
sensitive against specified antilymphocyte serum, which is ex-
haustively macrophage absorbed (2). Furthermore, no reactivity was 
observed when using third party target fibroblasts; that is, both 
GVHR and SCR appeared to be specific. 
DISCUSSION 
Two strain combinations strongly differing in GVHR induced 
mortality have been investigated. From the findings in Fig. 2, 
we conclude that mortality differences between the two strain 
combinations are hardly impressive when grafting only half SI, but 
quite impressive when grafting total SI. Strong differences occur 
eVen within one strain~combination when grafting half vs. total 
SI. Considering that the F344/CAP combination is characterized by 
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3 but the LEW/BN combination by 5 MHC mismatches, this difference 
in histoincompatibility, obviously fully effective only in full 
length grafts, could be regarded as a reasonable explanation for 
the differences in mortality. 
The most interesting finding concerning GVHR after SI trans-
plantation, namely, its compartmentalization, allows for·the 
hypothesis that lymphocytes may become the more aggressive to the 
host, the better they are able to move free in the blood. Once 
rats have survived the GVH-crisis between day 10 and 20, cytotoxic 
effector cells are missing in the transport compartment blood 
and appear to be "locked in" into the lymphoid tissue compartments. 
A similar "locking-in phenomenon" (nonreactivity in blood vs. 
reactivity in the splenic compartment) has been observed several 
years ago in rats specifically tolerating skin allografts (3). 
Additionally to this cell mediated phenomenon, serum factors 
become demonstrable which block cytotoxic effector cells in vitro. 
How far these two phenomena can be correlated and which the nature 
of the serum factor(s) is, awaits clarification. 
Autoantibodies, elicited by GVHR, were observed some years ago 
by Gleichmann and Gleichmann (4). On the other hand, an in vitro 
activation of Fl-hybrid cytotoxic T-lymphocytes specific for self 
H-2 has recently been described by the Cudkowicz group (5). The 
findings described here may be considered in this context and, 
even, regarded as a connecting link in that in vivo (rather than 
under the more or less artificial in vitro conditions) developing 
cell mediated autocytotoxicity (rather than auto-antibody 
production) has been observed. Concerning mortality, when seR as 
well as GVHR can be demonstrated in the transport compartment, the 
question must be raised whether it is SCR rather than GVHR which 
kills the graft recipients • 
• 
A number of questions call for further investigation: (a) 
What is the nature of the autoreactive cell? (b) From where does 
the autoreactive cell originate (Nakano et al. (5) found the Fl-
hybrid cell to be reactive)? (c) What is the meaning of the inde-
pendent kinetics of GVHR and SCR? (d) How far are both reactivities 
determined by the continuous supply of immunocompetent cells after 
SI transplantation? 
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